Touchlight is a privately-owned company based in London, U.K., focused on the provision of DNA services and manufacture of enzymatically produced DNA formats, such as doggybone DNA (dbDNA™) to enable the development of genetic medicines.
Touchlight DNA Services provide rapid, enzymatic DNA development and manufacturing for all advanced therapy production, including mRNA, viral and non-viral gene therapy and DNA API.
doggybone DNA (dbDNA) is a minimal, linear, covalently closed structure, that eliminates bacterial sequences. Touchlight’s revolutionary enzymatic production platform enables unprecedented speed, scale, and the ability to target genes with a size and complexity that is impossible with current technologies.
Clients can be supported from pre-clinical through development and supply, to licencing and tech transfer for use in-house.